Advancing HIV service delivery through pharmacies and pharmacists (R21 Clinical Trial Optional)

Ceiling: $200,000
Applications Due: Closed
Federal
U.S. Department of Health and Human Services - National Institutes of Health

Description

The purpose of this Notice of Funding Opportunity (NOFO) is to solicit research designed to capacitate, transform, and scale the delivery of HIV testing, prevention, and care services through pharmacists and pharmacies in US and/or global settings. This includes theadvancement of training curricula to enable pharmacy students, pharmacists, pharmacies, and pharmacy systems to deliver the spectrum of needed HIV services with ease, equity, and effectiveness. This NOFO uses the R21 grant mechanism, while RFA-MH-25-185 uses the R01 mechanism. Projects that lack preliminary data or that propose to pilot a novel intervention may be most appropriate for the R21 mechanism. Applications with preliminary data and those proposing large-scale clinical trials or longitudinal analyses should consider using the R01 mechanism.

Eligibility

States
All
Regions
All
Eligible Entities
State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal organizations, Public housing authorities, Nonprofits

Funding

Program Funding
$11,250,000
Award Ceiling
$200,000
Award Floor
Award Count
12

Timing

Posted Date
April 30, 2024
App Status
No Longer Accepting Applications
Pre-app Deadline
Application Deadline
August 13, 2024

Funder

Funding Source
Source Type
Federal
Contact Name
Contact Email
Contact Phone
--

Why Organizations Trust GrantExec

$78.81B
Available Funding
7,151
Active Grants
224
New Grants Analyzed This Week